ArticleOncotarget2016

Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.

Haiyong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.